SCHEMBL23819113

SCHEMBL23819113

CCC(CC)COC(=O)[C@H](C)NP(=O)(N[C@@H](C)C(=O)OC1CCCCC1)OCC(C#N)(OC)[C@@H](OC(C)=O)[C@@H](OC(C)=O)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23818683 0.95 RIPK1 (0.31) —
SCHEMBL23819003 0.93 — —
SCHEMBL26289550 0.90 — —
SCHEMBL23819055 0.86 RIPK1 (0.30) —
SCHEMBL23819180 0.86 RIPK1 (0.31) —
SCHEMBL23818637 0.85 — —
SCHEMBL23818668 0.85 RIPK1 (0.31) —
SCHEMBL26332496 0.85 RIPK1 (0.31) —
SCHEMBL23819343 0.82 — —
SCHEMBL26333768 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767337-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2023-09-26 — — US disclosed
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed
Send feedback